{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-23-000008","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.485279+00:00","generated_at":"2026-06-18T23:08:55.558734+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Myriad Genetics Q4 revenue $177.8M (+11% YoY); GAAP EPS $(0.52), adjusted EPS $(0.12)","bullets":["Q4 testing volumes up 26% YoY; hereditary cancer +16%, GeneSight +23%.","Full-year 2022 GeneSight revenue grew 36% to $127.6M.","FY2023 guidance: revenue $720-750M, adjusted EPS $(0.40)-$(0.20).","Q1 2023 guidance: revenue $170-172M, adjusted EPS $(0.20)-$(0.18).","Ended Q4 with $169.7M cash, no debt; cash used in ops $7.7M."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-23-000008","json":"https://secwatch.observer/filing/0000899923-23-000008.json","markdown":"https://secwatch.observer/filing/0000899923-23-000008.md","text":"https://secwatch.observer/filing/0000899923-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000008/0000899923-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000008/mygn-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:08:55.558734+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f2aeabbda02fb797e5a92e0ada3abb53b3f2480","claim":"MYRIAD GENETICS INC reported fourth quarter ended December 31, 2022 results: revenue $177.8 million, EPS $(0.52). Guidance initiated.","evidence_excerpt":"Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000008/0000899923-23-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$177.8 million"},{"label":"EPS","value":"$(0.52)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}